Cargando…
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
The well-known immunosuppressive drug cyclosporin A inhibits replication of various viruses including coronaviruses by binding to cellular cyclophilins thus inactivating their cis-trans peptidyl-prolyl isomerase function. Viral nucleocapsid proteins are inevitable for genome encapsidation and replic...
Autores principales: | Ma-Lauer, Yue, Zheng, Yu, Malešević, Miroslav, von Brunn, Brigitte, Fischer, Gunter, von Brunn, Albrecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114175/ https://www.ncbi.nlm.nih.gov/pubmed/31634494 http://dx.doi.org/10.1016/j.antiviral.2019.104620 |
Ejemplares similares
-
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2014) -
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication
por: von Brunn, Albrecht, et al.
Publicado: (2015) -
Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models
por: Berthold, Emilia J., et al.
Publicado: (2022) -
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2012) -
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19
por: Liu, Chenglong, et al.
Publicado: (2020)